Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
40
EDIT
Editas Medicine
Last Price:
2.53
Seasonality Move:
7.77%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.04 | Sell |
20-day SMA: | 3.11 | Sell |
50-day SMA: | 3.34 | Sell |
200-day SMA: | 5.33 | Sell |
8-day EMA: | 2.95 | Sell |
20-day EMA: | 3.08 | Sell |
50-day EMA: | 3.37 | Sell |
200-day EMA: | 5.1 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 35.77 | Sell |
Chaikin Money Flow: | -833782 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.92 - 3.38) | Sell |
Bollinger Bands (100): | (3.13 - 4.81) | Sell |
Editas Medicine Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 2.66 while EDIT 8-day simple moving average is 3.04, which is a Sell signal.
- The stock price of EDIT is 2.66 while Editas Medicine 20-day SMA is 3.11, which makes it a Sell.
- Editas Medicine 50-day simple moving average is 3.34 while EDIT share price is 2.66, making it a Sell technically.
- EDIT stock price is 2.66 and Editas Medicine 200-day simple moving average is 5.33, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
40
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Sell
The current Editas Medicine [EDIT] share price is $2.66. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
219.58M
Price in USD:
2.66
Share Volume:
2.5M
Editas Medicine 52-Week Range
52-Week High:
11.69
52-Week Low:
2.59
Sell
40
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 2.66 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 2.66 while EDIT 8-day exponential moving average is 2.95, which is a Sell signal.
- The stock price of EDIT is 2.66 while Editas Medicine 20-day EMA is 3.08, which makes it a Sell.
- Editas Medicine 50-day exponential moving average is 3.37 while EDIT share price is 2.66, making it a Sell technically.
- EDIT stock price is 2.66 and Editas Medicine 200-day simple moving average is 5.10, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 35.77, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (2.92 - 3.38), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (3.13 - 4.81), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.